Literature DB >> 19906004

Ovarian transplantation for fertility preservation in a sheep model: can follicle loss be prevented by antiapoptotic sphingosine-1-phosphate administration?

Katharina Hancke1, Elisabeth Walker, Oliver Strauch, Heike Göbel, Aida Hanjalic-Beck, Dominik Denschlag.   

Abstract

AIMS: The aim of this study was to investigate whether sphingosine-1-phosphate (S1P), an apoptosis-inhibitor would be able to protect ovarian follicles from hypoxia-induced cell death in ovarian transplantation.
METHODS: In four sheep, both ovaries were removed and immediately transplanted back into the abdominal wall. In two of them, one ovary was treated with S1P locally by injection and incubation after dissecting the ovarian cortex. The contra lateral ovary of both sheep and both ovaries of the remaining sheep served as controls. After 2 weeks, all grafts were evaluated histologically.
RESULTS: Although the mean number of apoptotic cells were increased after grafting compared with fresh tissue, we were not able to demonstrate a significant difference regarding the follicular density in tissue with S1P treatment (mean number of follicles per field of view: 0.21 vs. 0.23, p = 0.909).
CONCLUSION: Apoptosis seems to play a role in follicular loss during ovarian transplantation; however, local application of S1P does not prevent primordial/primary follicles from hypoxia-induced cell death in cortical grafts in our study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906004     DOI: 10.3109/09513590903159524

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  9 in total

1.  Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation.

Authors:  Zohar Gavish; Itay Spector; Gil Peer; Stefan Schlatt; Joachim Wistuba; Hadassa Roness; Dror Meirow
Journal:  J Assist Reprod Genet       Date:  2017-11-03       Impact factor: 3.412

2.  Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts.

Authors:  Yung-Chieh Tsai; Chii-Ruey Tzeng; Chia-Woei Wang; Ming-I Hsu; Shun-Jen Tan; Chi-Huang Chen
Journal:  Reprod Sci       Date:  2013-06-21       Impact factor: 3.060

3.  In vitro evaluation of the anti-apoptotic drug Z-VAD-FMK on human ovarian granulosa cell lines for further use in ovarian tissue transplantation.

Authors:  Maïté Fransolet; Laurie Henry; Soraya Labied; Agnès Noël; Michelle Nisolle; Carine Munaut
Journal:  J Assist Reprod Genet       Date:  2015-07-14       Impact factor: 3.412

4.  The beneficial effects of polyethylene glycol-superoxide dismutase on ovarian tissue culture and transplantation.

Authors:  Eun Jung Kim; Hee Jun Lee; Jaewang Lee; Hye Won Youm; Jung Ryeol Lee; Chang Suk Suh; Seok Hyun Kim
Journal:  J Assist Reprod Genet       Date:  2015-08-04       Impact factor: 3.412

5.  DNA repair in primordial follicle oocytes following cisplatin treatment.

Authors:  Quynh-Nhu Nguyen; Nadeen Zerafa; Jock K Findlay; Martha Hickey; Karla J Hutt
Journal:  J Assist Reprod Genet       Date:  2021-04-16       Impact factor: 3.357

6.  Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.

Authors:  Laurie Henry; Maïté Fransolet; Soraya Labied; Silvia Blacher; Marie-Caroline Masereel; Jean-Michel Foidart; Agnès Noel; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2016-02-12       Impact factor: 4.234

7.  Evaluation of an alternative heterotopic transplantation model for ovarian tissue to test pharmaceuticals improvements for fertility restoration.

Authors:  Carmen Terren; Jules Bindels; Michelle Nisolle; Agnès Noël; Carine Munaut
Journal:  Reprod Biol Endocrinol       Date:  2022-02-19       Impact factor: 5.211

8.  Heterotopic ovarian transplantation results in less apoptosis than orthotopic transplantation in a minipig model.

Authors:  Lia Cruz V C Damásio; José Maria Soares-Júnior; Jairo Iavelberg; Gustavo A R Maciel; Manuel de Jesus Simões; Ricardo Dos Santos Simões; Eduardo Vieira da Motta; Maria Cândida Pinheiro Baracat; Edmund C Baracat
Journal:  J Ovarian Res       Date:  2016-03-15       Impact factor: 4.234

9.  Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture.

Authors:  Carmen Terren; Michelle Nisolle; Carine Munaut
Journal:  J Ovarian Res       Date:  2021-07-19       Impact factor: 4.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.